The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use a concentration of 1 µg/ml. Detects a band of approximately 51 kDa (predicted molecular weight: 51 kDa).
Receptor for RNL3/relaxin-3. Binding of the ligand inhibit cAMP accumulation.
Expressed predominantly in brain regions. Highest expression in substantia nigra and pituitary, followed by hippocampus, spinal cord, amygdala, caudate nucleus and corpus callosum, quite low level in cerebellum. In peripheral tissues, relatively high levels in adrenal glands, low levels in pancreas, salivary gland, placenta, mammary gland and testis.
Belongs to the G-protein coupled receptor 1 family.
Relaxin/insulin like family peptide receptor 3 antibody
Relaxin3 receptor 1 antibody
Relaxin3 receptor1 antibody
RL3 R1 antibody
RL3R 1 antibody
RLN3 receptor 1 antibody
RLN3 receptor1 antibody
SALP R antibody
somatostatin and angiotensin like peptide receptor antibody
Somatostatin- and angiotensin-like peptide receptor antibody
Western blot - GPCR SALPR antibody (ab72914)
All lanes : Anti-Relaxin 3 receptor 1 antibody (ab72914) at 1 µg/ml
Lane 1 : Human brain tissue lysate - total protein (ab29466) Lane 2 : Human brain normal tissue lysate - membrane extract (ab29456) Lane 3 : Human spinal cord tissue lysate - total protein (ab29188) Lane 4 : SK N SH (Human neuroblastoma) Whole Cell Lysate Lane 5 : Human kidney tissue lysate - total protein (ab30203)
Lysates/proteins at 10 µg per lane.
Secondary Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution Developed using the ECL technique